Literature DB >> 23450302

Percent emphysema and right ventricular structure and function: the Multi-Ethnic Study of Atherosclerosis-Lung and Multi-Ethnic Study of Atherosclerosis-Right Ventricle Studies.

Maria Grau1, R Graham Barr2, Joao A Lima3, Eric A Hoffman4, David A Bluemke5, J Jeffrey Carr6, Harjit Chahal3, Paul L Enright7, Aditya Jain3, Martin R Prince8, Steven M Kawut9.   

Abstract

BACKGROUND: Severe COPD can lead to cor pulmonale and emphysema and is associated with impaired left ventricular (LV) filling. We evaluated whether emphysema and airflow obstruction would be associated with changes in right ventricular (RV) structure and function and whether these associations would differ by smoking status.
METHODS: The Multi-Ethnic Study of Atherosclerosis (MESA) performed cardiac MRI on 5,098 participants without clinical cardiovascular disease aged 45 to 84 years. RV and emphysema measures were available for 4,188 participants. Percent emphysema was defined as the percentage of voxels below -910 Hounsfield units in the lung windows on cardiac CT scans. Generalized additive models were used to control for confounders and adjust for respective LV parameters.
RESULTS: Participants consisted of 13% current smokers, 36% former smokers, and 52% never smokers. Percent emphysema was inversely associated with RV end-diastolic volume, stroke volume, cardiac output, and mass prior to adjustment for LV measures. After adjustment for LV end-diastolic volume, greater percent emphysema was associated with greater RV end-diastolic volume (+1.5 mL, P=.03) among current smokers, smaller RV end-diastolic volume (-0.8 mL, P=.02) among former smokers, and similar changes among never smokers.
CONCLUSIONS: Percent emphysema was associated with smaller RV volumes and lower mass. The relationship of emphysema to cardiac function is complex but likely involves increased pulmonary vascular resistance, predominantly with reduced cardiac output, pulmonary hyperinflation, and accelerated cardiopulmonary aging.

Entities:  

Mesh:

Year:  2013        PMID: 23450302      PMCID: PMC3704233          DOI: 10.1378/chest.12-1779

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  30 in total

1.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

Authors:  B R Celli; W MacNee
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

2.  Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study.

Authors:  J Jeffrey Carr; Jennifer Clark Nelson; Nathan D Wong; Michael McNitt-Gray; Yadon Arad; David R Jacobs; Stephan Sidney; Diane E Bild; O Dale Williams; Robert C Detrano
Journal:  Radiology       Date:  2005-01       Impact factor: 11.105

3.  Gravity is a minor determinant of pulmonary blood flow distribution.

Authors:  R W Glenny; W J Lamm; R K Albert; H T Robertson
Journal:  J Appl Physiol (1985)       Date:  1991-08

4.  Patterns of cardiovascular dysfunction in chronic obstructive lung disease.

Authors:  B Burrows; L J Kettel; A H Niden; M Rabinowitz; C F Diener
Journal:  N Engl J Med       Date:  1972-04-27       Impact factor: 91.245

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

Review 6.  Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part One.

Authors:  W MacNee
Journal:  Am J Respir Crit Care Med       Date:  1994-09       Impact factor: 21.405

Review 7.  State of the art: chronic cor pulmonale.

Authors:  A P Fishman
Journal:  Am Rev Respir Dis       Date:  1976-10

8.  Computed tomography-quantified emphysema distribution is associated with lung function decline.

Authors:  Firdaus A A Mohamed Hoesein; Eva van Rikxoort; Bram van Ginneken; Pim A de Jong; Mathias Prokop; Jan-Willem J Lammers; Pieter Zanen
Journal:  Eur Respir J       Date:  2012-02-09       Impact factor: 16.671

9.  Increased platelet aggregate formation in patients with chronic airflow obstruction and hypoxaemia.

Authors:  J A Wedzicha; D Syndercombe-Court; K C Tan
Journal:  Thorax       Date:  1991-07       Impact factor: 9.139

10.  Gravity-independent inequality in pulmonary blood flow in humans.

Authors:  T S Hakim; R Lisbona; G W Dean
Journal:  J Appl Physiol (1985)       Date:  1987-09
View more
  32 in total

1.  Right Ventricular Structure and Function Are Associated With Incident Atrial Fibrillation: MESA-RV Study (Multi-Ethnic Study of Atherosclerosis-Right Ventricle).

Authors:  Neal A Chatterjee; Ravi V Shah; Venkatesh L Murthy; Amy Praestgaard; Sanjiv J Shah; Corey E Ventetuolo; R Graham Barr; Richard Kronmal; Joao A C Lima; David A Bluemke; Michael Jerosch-Herold; Alvaro Alonso; Steven M Kawut
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-01

2.  Effects of the association of diabetes and pulmonary emphysema on cardiac structure and function in rats.

Authors:  Antonio Di Petta; Rafael Simas; Clebson L Ferreira; Vera L Capelozzi; Vera M C Salemi; Luiz F P Moreira; Paulina Sannomiya
Journal:  Int J Exp Pathol       Date:  2015-10-29       Impact factor: 1.925

3.  [COPD and heart disease].

Authors:  H Watz; M Arzt
Journal:  Herz       Date:  2014-02       Impact factor: 1.443

Review 4.  Perspective: ambient air pollution: inflammatory response and effects on the lung's vasculature.

Authors:  Gabriele Grunig; Leigh M Marsh; Nafiseh Esmaeil; Katelin Jackson; Terry Gordon; Joan Reibman; Grazyna Kwapiszewska; Sung-Hyun Park
Journal:  Pulm Circ       Date:  2014-03       Impact factor: 3.017

5.  H2 receptor antagonists and right ventricular morphology: the MESA right ventricle study.

Authors:  Peter J Leary; R Graham Barr; David A Bluemke; Michael R Bristow; Richard A Kronmal; Joao A Lima; David D Ralph; Corey E Ventetuolo; Steven M Kawut
Journal:  Ann Am Thorac Soc       Date:  2014-11

6.  Taking it to heart: dissecting cardiopulmonary interactions in diseases of the lung and the cardiovascular system.

Authors:  Tim Lahm
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-08-12       Impact factor: 5.464

7.  Pulmonary artery enlargement is associated with right ventricular dysfunction and loss of blood volume in small pulmonary vessels in chronic obstructive pulmonary disease.

Authors:  J Michael Wells; Anand S Iyer; Farbod N Rahaghi; Surya P Bhatt; Himanshu Gupta; Thomas S Denney; Steven G Lloyd; Louis J Dell'Italia; Hrudaya Nath; Raul San Jose Estepar; George R Washko; Mark T Dransfield
Journal:  Circ Cardiovasc Imaging       Date:  2015-04       Impact factor: 7.792

8.  Developing and Implementing Biomarkers and Novel Imaging in COPD.

Authors:  Surya P Bhatt; Meilan K Han
Journal:  Chronic Obstr Pulm Dis       Date:  2016-01-15

Review 9.  Should mild COPD be treated? Evidence for early pharmacological intervention.

Authors:  Amany F Elbehairy; Katherine A Webb; J Alberto Neder; J Alberto Neder; Denis E O'Donnell
Journal:  Drugs       Date:  2013-12       Impact factor: 9.546

10.  Percent Emphysema and Daily Motor Activity Levels in the General Population: Multi-Ethnic Study of Atherosclerosis.

Authors:  Christian M Lo Cascio; Mirja Quante; Eric A Hoffman; Alain G Bertoni; Carrie P Aaron; Joseph E Schwartz; Mark V Avdalovic; Vincent S Fan; Gina S Lovasi; Steven M Kawut; John H M Austin; Susan Redline; R Graham Barr
Journal:  Chest       Date:  2016-12-06       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.